Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Clinical efficacy and safety of maintenance therapy for advanced non-small cell lung cancer: a retrospective real-world study

Fig. 3

Influence of MT regimens and duration of chemotherapy or targeted drugs on PFS. Progression-free survival was prolonged after A > 4 cycles of chemotherapy and C > 3 months of targeted drugs (both P < 0.0001, log-rank tests). Effects of chemotherapy with pemetrexed, docetaxel, or paclitaxel on PFS did not significantly differ (P = 0.278, log-rank tests). MT, maintenance treatment; PFS, progression-free survival

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us